Thanks Ozzie. I get all of that. Patience? You have to be joking! We have waited years, some shareholders a decade. All for what? A share price at less than one cent?
I think some lessons here for BioTech investors. 2 I can think of very very very relevant for Oncosil.
(1) If there is no public reimbursement then there are no cash flows. Period. Company has burnt thru circa $100 million of shareholder funds.
(2) No FDA then you don’t get any market support. Especially from Insto’s. They want FDA before those guys commit.
That I reckon sums it up. All the other approvals, CE Mark, etc etc all mean Jack. It’s as simple as that.
OSL Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)